Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases

Pharmacology and Therapeutics

Volumn 111, Issue 3, 2006, Pages 555-566

  Pedemonte, Enrico ^a   Mancardi, Gianluigi ^a   Giunti, Debora ^a   Corcione, Anna ^b   Benvenuto, Federica ^a   Pistoia, Vito ^b   Uccelli, Antonio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Department of Experimental   (Italy)

Author keywords

Adaptive immunity; Blood brain barrier; Central nervous system; Cerebrospinal fluid; Experimental autoimmune encephalomyelitis; Multiple sclerosis

Indexed keywords

ANTIBODY PRODUCING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CERVICAL LYMPH NODE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INFLAMMATION; LEUKOCYTE MIGRATION; LYMPH NODE; LYMPHATIC SYSTEM; MEDICAL LITERATURE; MICROENVIRONMENT; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCIENCE; STRUCTURE ANALYSIS; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BLOOD-BRAIN BARRIER; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 33746366195     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.11.007     Document Type: Review

References (114)

1. Aloisi F., Ria F., Penna G., and Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160 (1998) 4671-4680
2. Aloisi F., Ria F., and Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 21 (2000) 141-147
3. Alt C., Laschinger M., and Engelhardt B. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 32 (2002) 2133-2144
4. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192 (2000) 393-404
5. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., and Janeway Jr. C.A. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177 (1993) 57-68
6. Battistini L., Selmaj K., Kowal C., Ohmen J., Modlin R.L., Raine C.S., et al. Multiple sclerosis: limited diversity of the V delta 2-J delta 3 T-cell receptor in chronic active lesions. Ann Neurol 37 (1995) 198-203
7. Berger J.R., and Koralnik I.J. Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequences. N Engl J Med 353 (2005) 414-416
8. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., and Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 (2000) 1174-1183
9. Bo L., Mork S., Kong P.A., Nyland H., Pardo C.A., and Trapp B.D. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51 (1994) 135-146
10. Bo L., Peterson J.W., Mork S., Hoffman P.A., Gallatin W.M., Ransohoff R.M., et al. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol 55 (1996) 1060-1072
11. Booss J., Esiri M.M., Tourtellotte W.W., and Mason D.Y. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62 (1983) 219-232
12. Borsellino G., Koul O., Placido R., Tramonti D., Luchetti S., Galgani S., et al. Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens. J Neuroimmunol 107 (2000) 124-129
13. Bradbury M.W., Cserr H.F., and Westrop R.J. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am J Physiol 240 (1981) 329-336
14. Broadwell R.D., Baker B.J., Ebert P.S., and Hickey W.F. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological and immunological considerations. Microsc Res Tech 27 (1994) 471-494
15. Cardona A.E., Restrepo B.I., Jaramillo J.M., and Teale J.M. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J Immunol 162 (1999) 995-1002
16. Carrithers M.D., Visintin I., Viret C., and Janeway Jr. C.S. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J Neuroimmunol 129 (2002) 51-57
17. Carson M.J., Reilly C.R., Sutcliffe J.G., and Lo D. Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol 154 (1999) 481-494
18. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128 (2005) 1667-1676
19. Colombo M., Dono M., Gazzola P., Roncella S., Valetto A., Chiorazzi N., et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164 (2000) 2782-2789
20. Columba-Cabezas S., Serafini B., Ambrosini E., and Aloisi F. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol 13 (2003) 38-51
21. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A 101 (2004) 11064-11069
22. Corcione A., Aloisi F., Serafini B., Capello E., Mancardi G.L., Pistoia V., et al. B Cell differentiation in the CNS of patients with multiple sclerosis. Autoimmun Rev 4 (2005) 549-554
23. Cserr H.F., and Knopf P.M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13 (1992) 507-512
24. Cserr H.F., Harling-Berg C.J., and Knopf P.M. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol 2 (1992) 269-276
25. de Vos A.F., van Meurs M., Brok H.P., Boven L.A., Hintzen R.Q., van der Valk P., et al. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol 169 (2002) 5415-5423
26. Engelhardt B., and Wolburg H. Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house?. Eur J Immunol 34 (2004) 2955-2963
27. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26 (2005) 485-495
28. Fife B.T., Huffnagle G.B., Kuziel W.A., and Karpus W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192 (2000) 899-905
29. Fife B.T., Kennedy K.J., Paniagua M.C., Lukacs N.W., Kunkel S.L., Luster A.D., et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166 (2001) 7617-7624
30. Fischer H.G., and Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 166 (2001) 2717-2726
31. Fischer H.G., Bonifas U., and Reichmann G. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J Immunol 164 (2000) 4826-4834
32. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14 (2001) 547-560
33. Gao Y.L., Rajan A.J., Raine C.S., and Brosnan C.F. Gammadelta T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis. J Autoimmun 17 (2001) 261-271
34. Gay F.W., Drye T.J., Dick G.W., and Esiri M.M. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 120 (1997) 1461-1483
35. Gijbels K., Masure S., Carton H., and Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41 (1992) 29-34
36. Gijbels K., Galardy R.E., and Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94 (1994) 2177-2182
37. Giunti D., Borsellino G., Benelli R., Marchese M., Capello E., Valle M.T., et al. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol 73 (2003) 584-590
38. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11 (1998) 328-334
39. Hanly A., and Petito C.K. HLA-DR-positive dendritic cells of the normal human choroid plexus: a potential reservoir of HIV in the central nervous system. Hum Pathol 29 (1998) 88-93
40. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hovelmeyer N., et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11 (2005) 146-152
41. Hickey W.F., and Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239 (1988) 290-292
42. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1 (1991) 97-105
43. Hickey W.F., Vass K., and Lassmann H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 51 (1992) 246-256
44. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 11 (1999) 125-137
45. Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system. Glia 36 (2001) 118-124
46. Huang D., Han Y., Rani M.R., Glabinski A., Trebst C., Sorensen T., et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177 (2000) 52-67
47. Hughes P.E., and Pfaff M. Integrin affinity modulation. Trends Cell Biol 8 (1998) 359-364
48. Imai F., Sawada M., Suzuki H., Kiya N., Hayakawa M., Nagatsu T., et al. Migration activity of microglia and macrophages into rat brain. Neurosci Lett 237 (1997) 49-52
49. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19 (2003) 47-57
50. Izikson L., Klein R.S., Charo I.F., Weiner H.L., and Luster A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 192 (2000) 1075-1080
51. Karman J., Ling C., Sandor M., and Fabry Z. Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol 173 (2004) 2353-2361
52. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., and Miller S.D. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155 (1995) 5003-5010
53. Kerfoot S.M., and Kubes P. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 169 (2002) 1000-1006
54. Kivisakk P., Mahad D.J., Callahan M.K., Trebst C., Tucky B., Wei T., et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A 100 (2003) 8389-8394
55. Kivisakk P., Mahad D.J., Callahan M.K., Sikora K., Trebst C., Tucky B., et al. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann Neurol 55 (2004) 627-638
56. Knopf P.M., Cserr H.F., Nolan S.C., Wu T.Y., and Harling-Berg C.J. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathol Appl Neurobiol 21 (1995) 175-180
57. Knopf P.M., Harling-Berg C.J., Cserr H.F., Basu D., Sirulnick E.J., Nolan S.C., et al. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J Immunol 161 (1998) 692-701
58. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96 (1999) 10711-10716
59. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201 (2005) 195-200
60. Lahrtz F., Piali L., Spanaus K.S., Seebach J., and Fontana A. Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol 85 (1998) 33-43
61. Lehmann P.V., Forsthuber T., Miller A., and Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358 (1992) 155-157
62. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., and Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 40 (1996) 846-852
63. Leppert D., Ford J., Stabler G., Grygar C., Lienert C., Huber S., et al. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121 (1998) 2327-2334
64. Liedtke W., Cannella B., Mazzaccaro R.J., Clements J.M., Miller K.M., Wucherpfennig K.W., et al. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann Neurol 44 (1998) 35-46
65. Liu L., Callahan M.K., Huang D., and Ransohoff R.M. Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol 68 (2005) 149-181
66. Lowhagen P., Johansson B.B., and Nordborg C. The nasal route of cerebrospinal fluid drainage in man. A light-microscope study. Neuropathol Appl Neurobiol 20 (1994) 543-550
67. Magliozzi R., Columba-Cabezas S., Serafini B., and Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 148 (2004) 11-23
68. Magnus T., Schreiner B., Korn T., Jack C., Guo H., Antel J., et al. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 25 (2005) 2537-2546
69. Matyszak M.K., and Perry V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74 (1996) 599-608
70. Matyszak M.K., and Perry V.H. Bacillus Calmette-Guerin sequestered in the brain parenchyma escapes immune recognition. J Neuroimmunol 82 (1998) 73-80
71. McMenamin P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J Comp Neurol 405 (1999) 553-562
72. Mun-Bryce S., and Rosenberg G.A. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274 (1998) R1203-R1211
73. Myers K.J., Dougherty J.P., and Ron Y. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J Immunol 151 (1993) 2252-2260
74. Nick S., Pileri P., Tongiani S., Uematsu Y., Kappos L., and De Libero G. T cell receptor gamma delta repertoire is skewed in cerebrospinal fluid of multiple sclerosis patients: molecular and functional analyses of antigen-reactive gamma delta clones. Eur J Immunol 25 (1995) 355-363
75. Olson J.K., and Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173 (2004) 3916-3924
76. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., et al. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 44 (1998) 592-600
77. Peterson J.W., Bo L., Mork S., Chang A., Ransohoff R.M., and Trapp B.D. VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J Neuropathol Exp Neurol 61 (2002) 539-546
78. Phillips L.M., and Lampson L.A. Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-gamma. J Neuroimmunol 96 (1999) 218-227
79. Piccio L., Rossi B., Scarpini E., Laudanna C., Giagulli C., Issekutz A.C., et al. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J Immunol 168 (2002) 1940-1949
80. Provencio J.J., Kivisakk P., Tucky B.H., Luciano M.G., and Ransohoff R.M. Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients. J Neuroimmunol 163 (2005) 179-184
81. Qing Z., Sandor M., Radvany Z., Sewell D., Falus A., Potthoff D., et al. Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J Neuropathol Exp Neurol 60 (2001) 798-807
82. Rajan A.J., Asensio V.C., Campbell I.L., and Brosnan C.F. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J Immunol 164 (2000) 2120-2130
83. Ransohoff R.M. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J Neuroimmunol 98 (1999) 57-68
84. Ransohoff R.M., Kivisakk P., and Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3 (2003) 569-581
85. Rosenberg G.A., Kornfeld M., Estrada E., Kelley R.O., Liotta L.A., and Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 576 (1992) 203-207
86. Sallusto F., and Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189 (1999) 611-614
87. Santambrogio L., Belyanskaya S.L., Fischer F.R., Cipriani B., Brosnan C.F., Ricciardi-Castagnoli P., et al. Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A 98 (2001) 6295-6300
88. Schwartz M., and Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci 233 (2005) 163-166
89. Seabrook T.J., Johnston M., and Hay J.B. Cerebral spinal fluid lymphocytes are part of the normal recirculating lymphocyte pool. J Neuroimmunol 91 (1998) 100-107
90. Sellebjerg F., Christiansen M., Jensen J., and Frederiksen J.L. Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. Eur J Neurol 7 (2000) 281-289
91. Selmaj K., Brosnan C.F., and Raine C.S. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A 88 (1991) 6452-6456
92. Serafini B., Columba-Cabezas S., Di Rosa F., and Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 157 (2000) 1991-2002
93. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., and Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14 (2004) 164-174
94. Shresta S., Pham C.T., Thomas D.A., Graubert T.A., and Ley T.J. How do cytotoxic lymphocytes kill their targets?. Curr Opin Immunol 10 (1998) 581-587
95. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., et al. Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci 101 (2004) 2428-2433
96. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103 (1999) 807-815
97. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
98. Steffen B.J., Butcher E.C., and Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 145 (1994) 189-201
99. Stevenson P.G., Bangham C.R., and Hawke S. Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site. Eur J Immunol 27 (1997) 3259-3268
100. Stevenson P.G., Freeman S., Bangham C.R., and Hawke S. Virus dissemination through the brain parenchyma without immunologic control. J Immunol 159 (1997) 1876-1884
101. Stuve O., Dooley N.P., Uhm J.H., Antel J.P., Francis G.S., Williams G., et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40 (1996) 853-863
102. Tan L., Gordon K.B., Mueller J.P., Matis L.A., and Miller S.D. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J Immunol 160 (1998) 4271-4279
103. Thompson E.J., and Keir G. Laboratory investigation of cerebrospinal fluid proteins. Ann Clin Biochem 27 (1990) 425-435
104. Tran E.H., Hoekstra K., van Rooijen N., Dijkstra C.D., and Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161 (1998) 3767-3775
105. Trapani J.A., Davis J., Sutton V.R., and Smyth M.J. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 12 (2000) 323-329
106. Tubridy N., Behan P.O., Capildeo R., Chaudhuri A., Forbes R., Hawkins C.P., et al. The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology 53 (1999) 466-472
107. Tuohy V.K., Yu M., Weinstock-Guttman B., and Kinkel R.P. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 99 (1997) 1682-1690
108. Uccelli A., Aloisi F., and Pistoia V. Unveiling the enigma of the central nervous system as a favourable environment for the induction of humoral immunity. Trends in Immunology 26 (2005) 254-259
109. Vass K., Lassmann H., Wekerle H., and Wisniewski H.M. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol 70 (1986) 149-160
110. Weller R.O., Engelhardt B., and Phillips M.J. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol 6 (1996) 275-288
111. Williams K.C., Zhao R.W., Ueno K., and Hickey W.F. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat. J Neurosci Res 45 (1996) 747-757
112. Yeager M.P., DeLeo J.A., Hoopes P.J., Hartov A., Hildebrandt L., and Hickey W.F. Trauma and inflammation modulate lymphocyte localization in vivo: quantitation of tissue entry and retention using indium-111-labeled lymphocytes. Crit Care Med 28 (2000) 1477-1482
113. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., and Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356 (1992) 63-66
114. Yushchenko M., Weber F., Mader M., Scholl U., Maliszewska M., Tumani H., et al. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J Neuroimmunol 110 (2000) 244-251